Efectividad del tratamiento con paricalcitol por vía oral en pacientes con enfermedad renal crónica en etapas anteriores a la diálisis
Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease
Leído
37071
Vecesse ha leído el artículo
3244
Total PDF
33827
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 175 | 90 | 265 |
| 2025 5 | 198 | 47 | 245 |
| 2025 4 | 202 | 31 | 233 |
| 2025 3 | 242 | 53 | 295 |
| 2025 2 | 199 | 27 | 226 |
| 2025 1 | 208 | 28 | 236 |
| 2024 12 | 335 | 31 | 366 |
| 2024 11 | 168 | 50 | 218 |
| 2024 10 | 183 | 42 | 225 |
| 2024 9 | 294 | 26 | 320 |
| 2024 8 | 256 | 56 | 312 |
| 2024 7 | 186 | 37 | 223 |
| 2024 6 | 177 | 54 | 231 |
| 2024 5 | 257 | 53 | 310 |
| 2024 4 | 261 | 38 | 299 |
| 2024 3 | 225 | 23 | 248 |
| 2024 2 | 219 | 41 | 260 |
| 2024 1 | 294 | 29 | 323 |
| 2023 12 | 145 | 28 | 173 |
| 2023 11 | 231 | 39 | 270 |
| 2023 10 | 218 | 40 | 258 |
| 2023 9 | 229 | 40 | 269 |
| 2023 8 | 279 | 26 | 305 |
| 2023 7 | 283 | 28 | 311 |
| 2023 6 | 344 | 19 | 363 |
| 2023 5 | 323 | 33 | 356 |
| 2023 4 | 293 | 14 | 307 |
| 2023 3 | 323 | 19 | 342 |
| 2023 2 | 265 | 31 | 296 |
| 2022 1 | 244 | 21 | 265 |
| 2022 12 | 151 | 31 | 182 |
| 2022 11 | 221 | 36 | 257 |
| 2022 10 | 217 | 53 | 270 |
| 2022 9 | 217 | 38 | 255 |
| 2022 8 | 171 | 48 | 219 |
| 2022 7 | 143 | 45 | 188 |
| 2022 6 | 176 | 46 | 222 |
| 2022 5 | 223 | 29 | 252 |
| 2022 4 | 207 | 49 | 256 |
| 2022 3 | 188 | 54 | 242 |
| 2022 2 | 197 | 67 | 264 |
| 2021 1 | 161 | 37 | 198 |
| 2021 12 | 120 | 51 | 171 |
| 2021 11 | 176 | 64 | 240 |
| 2021 10 | 260 | 103 | 363 |
| 2021 9 | 177 | 50 | 227 |
| 2021 8 | 201 | 40 | 241 |
| 2021 7 | 189 | 35 | 224 |
| 2021 6 | 242 | 42 | 284 |
| 2021 5 | 224 | 51 | 275 |
| 2021 4 | 619 | 110 | 729 |
| 2021 3 | 322 | 46 | 368 |
| 2021 2 | 337 | 24 | 361 |
| 2020 1 | 222 | 30 | 252 |
| 2020 12 | 181 | 30 | 211 |
| 2020 11 | 190 | 20 | 210 |
| 2020 10 | 177 | 18 | 195 |
| 2020 9 | 178 | 19 | 197 |
| 2020 8 | 142 | 26 | 168 |
| 2020 7 | 180 | 25 | 205 |
| 2020 6 | 231 | 21 | 252 |
| 2020 5 | 301 | 25 | 326 |
| 2020 4 | 277 | 36 | 313 |
| 2020 3 | 228 | 22 | 250 |
| 2020 2 | 379 | 24 | 403 |
| 2020 1 | 294 | 22 | 316 |
| 2019 12 | 195 | 22 | 217 |
| 2019 11 | 152 | 20 | 172 |
| 2019 10 | 221 | 23 | 244 |
| 2019 9 | 235 | 26 | 261 |
| 2019 8 | 491 | 23 | 514 |
| 2019 7 | 279 | 28 | 307 |
| 2019 6 | 265 | 27 | 292 |
| 2019 5 | 294 | 24 | 318 |
| 2019 4 | 321 | 42 | 363 |
| 2019 3 | 219 | 28 | 247 |
| 2019 2 | 151 | 20 | 171 |
| 2019 1 | 165 | 18 | 183 |
| 2018 12 | 226 | 39 | 265 |
| 2018 11 | 389 | 18 | 407 |
| 2018 10 | 406 | 22 | 428 |
| 2018 9 | 391 | 12 | 403 |
| 2018 8 | 339 | 19 | 358 |
| 2018 7 | 314 | 15 | 329 |
| 2018 6 | 339 | 11 | 350 |
| 2018 5 | 362 | 17 | 379 |
| 2018 4 | 235 | 11 | 246 |
| 2018 3 | 182 | 12 | 194 |
| 2018 2 | 131 | 8 | 139 |
| 2018 1 | 188 | 10 | 198 |
| 2017 12 | 108 | 13 | 121 |
| 2017 11 | 131 | 8 | 139 |
| 2017 10 | 123 | 6 | 129 |
| 2017 9 | 202 | 9 | 211 |
| 2017 8 | 193 | 9 | 202 |
| 2017 7 | 166 | 10 | 176 |
| 2017 6 | 144 | 14 | 158 |
| 2017 5 | 172 | 14 | 186 |
| 2017 4 | 123 | 9 | 132 |
| 2017 3 | 157 | 9 | 166 |
| 2017 2 | 358 | 6 | 364 |
| 2016 1 | 172 | 7 | 179 |
| 2016 12 | 179 | 13 | 192 |
| 2016 11 | 242 | 9 | 251 |
| 2016 10 | 293 | 18 | 311 |
| 2016 9 | 453 | 7 | 460 |
| 2016 8 | 616 | 11 | 627 |
| 2016 7 | 414 | 16 | 430 |
| 2016 6 | 275 | 0 | 275 |
| 2016 5 | 241 | 0 | 241 |
| 2016 4 | 209 | 0 | 209 |
| 2016 3 | 170 | 0 | 170 |
| 2016 2 | 204 | 0 | 204 |
| 2015 1 | 215 | 0 | 215 |
| 2015 12 | 231 | 0 | 231 |
| 2015 11 | 202 | 0 | 202 |
| 2015 10 | 203 | 0 | 203 |
| 2015 9 | 177 | 0 | 177 |
| 2015 8 | 162 | 0 | 162 |
| 2015 7 | 230 | 0 | 230 |
| 2015 6 | 158 | 0 | 158 |
| 2015 5 | 232 | 0 | 232 |
| 2015 4 | 73 | 0 | 73 |
| 2015 2 | 4734 | 0 | 4734 |
Mostrar todo
